240 related articles for article (PubMed ID: 9452278)
41. Silver staining of nucleolar organizer regions in prostatic lesions.
Ghazizadeh M; Sasaki Y; Oguro T; Aihara K
Histopathology; 1991 Oct; 19(4):369-72. PubMed ID: 1718838
[TBL] [Abstract][Full Text] [Related]
42. 5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies.
Alsugair Z; Kepenekian V; Fenouil T; Glehen O; Villeneuve L; Isaac S; Hommell-Fontaine J; Benzerdjeb N
Virchows Arch; 2022 Jul; 481(1):23-29. PubMed ID: 35575935
[TBL] [Abstract][Full Text] [Related]
43. A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors.
Adeyemi BF; Kolude BM; Akang EE; Lawoyin JO
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):513-20. PubMed ID: 16997120
[TBL] [Abstract][Full Text] [Related]
44. Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach.
Kradin RL; Mark EJ
Semin Diagn Pathol; 2006 Feb; 23(1):4-14. PubMed ID: 17044190
[TBL] [Abstract][Full Text] [Related]
45. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
[TBL] [Abstract][Full Text] [Related]
46. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
47. Pleural multicystic mesothelial proliferation: a mimicker of benign peritoneal mesothelioma.
Agarwal S; Mullick S; Gupta K; Prasad S
Indian J Pathol Microbiol; 2013; 56(4):476-7. PubMed ID: 24441257
[No Abstract] [Full Text] [Related]
48. Morphometric analysis of argyrophilic nucleolar organizer regions (AgNORs) in nasopharyngeal carcinoma.
Pak MW; To KF; Chen MH; Lo SY; Lam PK; van Hasselt CA
Head Neck; 2000 Dec; 22(8):760-4. PubMed ID: 11084635
[TBL] [Abstract][Full Text] [Related]
49. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
50. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
51. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
52. Value of argyrophilic nucleolar organizing region protein determinations in nondiagnostic fine needle aspiration samples (due to insufficient cell groups) of thyroid nodules.
Eröz R; Unluhizarci K; Cucer N; Ozturk F
Anal Quant Cytopathol Histpathol; 2013 Aug; 35(4):226-31. PubMed ID: 24341126
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
Simha M; Menon M; Doctor V
Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
[TBL] [Abstract][Full Text] [Related]
54. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
Chen M; Lee JC; Lo S; Shen J
Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies.
Roberts F; Harper CM; Downie I; Burnett RA
Am J Clin Pathol; 2001 Aug; 116(2):253-62. PubMed ID: 11488073
[TBL] [Abstract][Full Text] [Related]
56. Benign pleural lesion and malignant mesothelioma.
Klima M; Gyorkey F
Virchows Arch A Pathol Anat Histol; 1977 Nov; 376(3):181-93. PubMed ID: 145715
[TBL] [Abstract][Full Text] [Related]
57. Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma.
Sington JD; Morris LS; Nicholson AG; Coleman N
Histopathology; 2003 May; 42(5):498-502. PubMed ID: 12713628
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
59. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
Naik R; Raghuveer CV; Jacob DL
J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
[TBL] [Abstract][Full Text] [Related]
60. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
Hansen AB; Ostergård B
Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):9-13. PubMed ID: 1694333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
